Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans
AssigneeBrock University
InventorsTomas Hudlicky, Mary Ann Endoma-Arias
Life of this patent
Estimating the term…
Abstract
The oxazolidine derived from the reaction of oxymorphone with the Burgess reagent, temporarily protected at 0-3 and C-6, reacts with Grignard or other suitable metallic or organometallic reagents to directly provide, for example, A/-allyl, A/-methylcyclopropyl and /V-methylcyclobutyl derivatives that are further converted into naltrexone, naloxone, nalbuphone and nalbuphine in excellent yields. These morphine analogs can be prepared from the oxazolidine in a one-pot synthesis.
Claims36
A process for the preparation of a compound of Formula I:
- wherein
- represents a single or double bond, provided that two double bonds are not adjacent to each other;
- R1 is selected from C3-10cycloalkyl, C3-10cycloalkenyl, C1-10alkyl, C2-10alkenyl, C6-10aryl, C1-10alkyleneC6-10aryl and C1-10alkyleneC3-10cycloalkyl;
- and
- R2 and R3 are independently selected from H, C1-10alkyl, C1-10acyl, C6-10aryl, C3-10cycloalkyl, C1-10alkyleneC6-10aryl and C1-10alkyleneC3-10cycloalkyl, except when O represents ═O, then R3 is not present;
- the process comprising:
- (a) reacting a compound of Formula II or a protected form thereof:
- wherein
- represents a single or double bond, provided that two double bonds are not adjacent to each other;
- and
- R2 and R3 are independently selected from H, C1-10alkyl, C1-10acyl, C6-10aryl, C3-10cycloalkyl, C1-10alkyleneC6-10aryl and C1-10alkyleneC3-10cycloalkyl, except when O represents ═O, then R3 is not present;
- with a reagent of Formula III:
- R1A III,
- wherein R1 is selected from C1-10alkyl, C2-10alkenyl, C3-10cycloalkyl, C3-10cycloalkenyl, C6-10aryl, C1-10alkyleneC6-10aryl and C1-10alkyleneC3-10cycloalkyl;
- and
- A is a suitable metallic or organometallic countercation;
- and
- (b) optionally deprotecting the compound derived from reacting the compound of Formula II or protected form thereof with the reagent of Formula III;
- under conditions to provide a compound of Formula I;
- wherein in the compounds of Formulae I, II and III one or more available hydrogens in R1, R2 and R3 is/are optionally replaced with F and/or one or more of available atoms in R1, R2 and R3 is/are optionally replaced with an isotopic label.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.